Ocugen OCGN
NASDAQ OCGN
$1.36 +0.01 (+0.74%)
At close: Sep 4, 2026 · 4:00 PM EDT

Ocugen (OCGN) Enterprise Value (2019 - 2026)

Ocugen's (OCGN) quarterly Enterprise Value came in at -$37.8 million in Q1 2025, down 43.32% YoY from -$66.7 million in Q1 2024, and down 140.81% on a QoQ basis from -$15.7 million in Q2 2024.

Analysis

Ocugen (OCGN) Enterprise Value (2019 - 2026) Analysis & Trends

Ocugen (OCGN) has 12 years of Enterprise Value data on file, last reported at -$37.8 million in Q1 2025.

  • Quarterly Enterprise Value fell 43.32% year-over-year to -$37.8 million in Q1 2025, while the trailing twelve-month figure through Mar 2025 was -$37.8 million (down 43.32% YoY) and the FY2023 annual result came in at -$39.5 million, up 56.6% from the prior year.
  • Enterprise Value slipped to -$37.8 million in Q1 2025, from -$15.7 million in the prior quarter.
  • In the past five years, Enterprise Value ranged from a high of -$15.7 million in Q2 2024 to a low of -$129.8 million in Q1 2022.
  • A 5-year average of -$75.7 million and a median of -$76.7 million in 2023 frame the typical range for Enterprise Value.
  • Annual changes were most pronounced in 2021 — Enterprise Value slumped 1459.04% — and 2024, when it jumped 77.76%.
  • Tracing OCGN's Enterprise Value over 5 years: stood at -$95.0 million in 2021, then climbed by 4.24% to -$90.9 million in 2022, then jumped by 56.6% to -$39.5 million in 2023, then soared by 60.22% to -$15.7 million in 2024, then slumped by 140.81% to -$37.8 million in 2025.
  • The last three Enterprise Value figures came in at -$37.8 million (Q1 2025), -$15.7 million (Q2 2024), and -$26.4 million (Q1 2024), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Ocugen 458.91 Mn 358.81 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 418.64 Mn
Mar 31, 2026 612.36 Mn
Dec 31, 2025 403.14 Mn
Sep 30, 2025 509.08 Mn
Jun 30, 2025 256.53 Mn
Mar 31, 2025 168.46 Mn
Dec 31, 2024 234.55 Mn
Sep 30, 2024 288.00 Mn
Jun 30, 2024 383.31 Mn
Mar 31, 2024 395.61 Mn
Dec 31, 2023 108.06 Mn
Sep 30, 2023 49.12 Mn
Jun 30, 2023 68.72 Mn
Mar 31, 2023 160.63 Mn
Dec 31, 2022 197.15 Mn
Sep 30, 2022 284.10 Mn
Jun 30, 2022 375.65 Mn
Mar 31, 2022 581.81 Mn
Dec 31, 2021 812.22 Mn
Sep 30, 2021 1.32 Bn